Cepheid's Q4 Revenues Rise 30 Percent | GenomeWeb

This article has been updated with comments and additional information from the firm's conference call.

NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market Thursday that its fourth-quarter revenues increased 30 percent on strong instrument and reagent growth.

The Sunnyvale, Calif.-based molecular diagnostics firm brought in total revenues of $49.2 million for the three-month period ended Dec. 31, compared to $37.8 million for the fourth quarter of 2008. The company easily beat analysts' consensus estimate of $45.4 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.